Table 3.
Ref. | Patient no. | Intestinal layer | Location | Previous treatment | Response |
Neustrom et al[63], 1999 | 1 | Mucosal | Esophagus + stomach + small intestine | Failure of response to elimination diet, cromolyn sodium, ranitidine and hydroxyzine | Clinical and histologic response (+) |
Schwartz et al[64], 2001 | 1 | Serosal | Duodenum | Steroid dependent | Remission (+) over 4 wk |
Lu et al[65], 2003 | 2 | Mucosal | - | Steroid dependent | 1 → Not effective |
2 → Partial response with tapering of prednisone to 10 mg/d | |||||
Vanderhoof et al[66], 2003 | 8 | Mucosal | Esophagus (n = 4) Duodenum (n = 2) Colon (n = 2) | Failure of standard therapies | Clinical response (+) within 1 mo |
Copeland et al[9], 2004 | 1 | Mucosal | Stomach | Steroid refractory EGE (also receiving 6MP and 5ASA for UC) | Not effective |
Friesen et al[67], 2004 | 40 | Mucosal | Duodenum | None | Response (+) within 2 wk |
Quack et al[68], 2005 | 1 | Serosal | Ileum | Steroid dependent | Remission (+) over 2 yr |
Urek et al[21], 2006 | 1 | Serosal | Ileum | Steroid dependent | Response (+) within 4 wk |
De Maeyer et al[69], 2011 | 1 | - | - | Steroid dependent | Response (+) |
Tien et al[5], 2011 | 12 | Mucosal | Stomach + duodenum + colon + esophagus | 4 → None 8 → Steroid dependent | Remission (+) over 12 mo 4/8 → Successful steroid tapering 3/8 → Not effective 1/8 → Lost to follow-up |
Selva Kumar et al[70], 2011 | 1 | Mucosal | Small intestine | Unresponsive to standard therapy | Response (+) |
Müller et al[26], 2014 | 2 | Mucosal (+/- serosal or muscular) | Stomach + small intestine | 1 and 2 → Steroid dependent | 1 → Remission (+) in combination with low-dose prednisone 2 → Remission (+) (off steroids) |
Wong et al[15], 2015 | 2 | Mucosal (+/- serosal or muscular) | - | 1: Steroid dependent 2: None | Remission (+) for 36 mo (in combination with prednisone) Asymptomatic for 10 mo |
5ASA: 5-Aminosalicylic acid; 6MP: 6 Mercaptopurine; UC: Ulcerative colitis.